Wegovy portfolio growth shifts to the pill as injectable sales forecast to plateau
In December 2025, the FDA approved the first-ever GLP-1 pill for chronic weight management - Novo Nordisk’s oral formulation of…
Analyst Comment
US vaccine manufacturers set to lose as RFK pushes for weaker vaccine mandates
GlobalData’s key thoughts from World EPA Congress 2026
Multiple Myeloma Awareness Month: the current and future landscape
SLE and LN market expected to reach $5.9bn across 7MM by 2034
Significant opportunities exist in the global pain market for novel mechanisms and modalities
Market instability expected from South Korea’s new pricing reform in 2026-2028
AbbVie’s $100bn deal aligns drug pricing with domestic manufacturing goals
